BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
LifeSpan is the industry leader in molecular pathology. LifeSpan sells antibodies, immunohistochemistry services and localization databases. Founded in 1995, LifeSpan has developed proprietary antibodies to major classes of drug targets to study the expression of these proteins in normal and diseased human tissues. LifeSpan is also a leader in high-throughput imaging and cancer recognition software and is developing instruments and software for pathology interpretation in preclinical toxicology and cancer diagnostics. LifeSpan's clients include more than 100 pharmaceutical companies in the United States, Europe, and Japan.
Chairman, President, and CEO
Joseph BrownNumber of Employees 74
Contact Information
2401 Fourth Ave Ste 900
Seattle, Washington 98121
1 206 464 1554
Peer Companies
NAICS Code Medical Laboratories: 621511
News & Analysis
Filter by
lifespan biosciences inc. - All News and Analysis
LifeSpan BioSciences to Release 20,000 Immunohistochemistry-Validated Reagent Antibodies
- 2008-06-12
Leader in Antibody Evaluation and Validation Expands Focus to Include Development and Sales of Antibodies Validated for Use in Immunohistochemistry SEATTLE -- LifeSpan BioSciences, Inc., today announced an initiative to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years. The leader in immunohistochemistry IHC antibody validation research since...
LifeSpan BioSciences Enters into Agreement with Roche for Expanded DrugTarget™ Localization Database
- 2007-01-30
SEATTLE -- LifeSpan BioSciences, Inc., a leading antibody company specializing in immunohistochemistry and antibodies to drug target proteins, today announced a multi-year agreement with Roche for a subscription to LifeSpan's DrugTarget DatabaseTM.
The US subsidiary of Japan's Medical and Biological Laboratories acquired LifeSpan BioSciences' inventory of more than 900 antibodies, including exclusive research reagent rights, in February
- 2006-04-30
The US subsidiary of Japan's Medical and Biological Laboratories MBL acquired LifeSpan BioSciences' inventory of more than 900 antibodies, including exclusive research reagent rights, in February. Under a multiyear agreement, MBL will distribute antibodies for gene targets developed by LifeSpan.
MBL International Acquires Antibody Business from LifeSpan
- 2006-02-14
Tokyo, Feb 14, 2006 - JCN - Medical and Biological Laboratories MBL announced on February 13 that its Massachusetts-based subsidiary MBL International has acquired the antibody business of LifeSpan BioSciences LifeSpan of Seattle. LifeSpan is a bio venture company that offers a wide range of antibodies, namely...
LifeSpan BioSciences, Inc. and MBL International Corporation Announce Multi-Year Licensing and Asset Agreement
- 2006-02-06
SEATTLE & WOBURN, Mass. -- LifeSpan BioSciences, Inc. ("LifeSpan") and MBL International Corporation ("MBLI"), a wholly owned subsidiary of Medical and Biological Laboratories Co., Ltd. (Nagoya, Japan), announced today a multi-year relationship in which MBLI will distribute antibodies to druggable gene targets that LifeSpan has developed and commercialized. As part...
LifeSpan BioSciences Announces Agreement With Pfizer for Expanded DrugTarget™ Localization Database
- 2005-12-21
SEATTLE -- LifeSpan BioSciences, Inc., a leading proteomics company specializing in molecular pathology, today announced a multi-year agreement with Pfizer Inc. (NYSE:PFE).
LifeSpan Biosciences and NEC Reach Milestones in Development of Cancer Diagnosis Support System
- 2005-05-23
Wireless News 05-23-2005 LifeSpan Biosciences and NEC Reach Milestones in Development of Cancer Diagnosis Support System WIRELESS NEWS-May 23, 2005-LifeSpan Biosciences and NEC Reach Milestones in Development of Cancer Diagnosis Support System C2005 10Meters - http://www.10meters.com ...
LifeSpan Biosciences and NEC Reach Milestones in Development of Cancer Diagnosis Support System
- 2005-05-23
SEATTLE -- LifeSpan BioSciences, NEC Corporation and NEC Soft of Japan have reached significant milestones in their collaboration to develop a cancer diagnosis support system to meet the needs of pathologists, physicians and patients for rapid and accurate detection and diagnosis of disease. E[acute accent]The diagnostic assistant, based on jointly...
LifeSpan BioSciences Announces Collaboration with Pfizer to Develop Automated Pathology Systems
- 2005-03-03
SEATTLE -- LifeSpan BioSciences Inc. today announced that they have entered into an agreement with Pfizer Inc (NYSE:PFE) to develop an automated pathology system for rapid and accurate evaluation of tissue specimens in preclinical studies.
LifeSpan BioSciences Enters into Agreement with Major Pharmaceutical Company for Expanded DrugTarget Localization Database
- 2004-08-23
SEATTLE -- LifeSpan BioSciences, Inc., a leading proteomics company specializing in molecular pathology, today announced an agreement, valued at $2 million, with an undisclosed major international pharmaceutical company for a subscription to LifeSpan's DrugTarget DatabaseTM. This subscription agreement marks the 50th subscriber to LifeSpan's DrugTarget data. LifeSpan's DrugTarget Database...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew Elston | Senior Director of Sales and Marketing |
| Dietmar Baas | Director of Sales, Europe |
| James W Shepperd |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Joseph Brown | Chairman, President, and CEO |
| Organization | Position | Status |
|---|---|---|
| Lifespan Biosciences, Inc. | Chairman, President, and CEO | Current |
| Organization | Position | Status |
|---|---|---|
| Lifespan Biosciences, Inc. | Senior Director of Sales and Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Lifespan Biosciences, Inc. | Director of Sales, Europe | Current |
Jim Shepperd is a CPA with more than 20 years experience in financial administration and oversight of both publicly and privately held companies, primarily in the banking and technology sectors. Jim's background includes senior positions at a number of regional and national financial institutions, including CFO for KeyBank of Oregon and Senior VP of Administration for KeyCorp's Northwest region, and he has accepted both full and part-time positions as CFO at a number of start-up and early stage companies, most recently with Lifespan Biosciences and SAFLINK Corporation.
| Organization | Position | Status |
|---|---|---|
| Corporate Finance Resources, Inc | Chief Financial Officer | Current |
| Lifespan Biosciences, Inc. | Current | |
| SAFLINK Corporation | Current | |
| Corporate Finance Resources, Inc | Financial Consultant | Former |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
Glass Door
Health Care Industry Companies
| Company | Employer Rating |
| Kaiser Permanente |  |
| Boston Scientific |  |
| WellPoint | |
| UnitedHealth Group |  |
| CIGNA | |
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
